Chung Hin Chui
Research Subjects
Research Interests
Chung Hin Chui has a total of 75 co-authors. Here are the top co-authors by number of shared publications:
- Kim-Hung Lam
The Hong Kong Polytechnic University
13 shared publications - Roberto Gambari
University of Ferrara
13 shared publications - Kenneth Ka Ho Lee
Key Laboratory for Regenerative Medicine of the Ministry of Education, School of Biomedical Sciences, Chinese University of Hong Kong, Shatin, Hong Kong
10 shared publications - Wai-Yeung Wong
Department of Chemistry and Research Institute for Smart Energy The Hong Kong Polytechnic University Hong Kong P. R. China
10 shared publications - Stanton Hon Lung Kok
School of Biomedical Sciences, The Chinese University of Hong Kong, P. R. China
9 shared publications - Johnny Cheuk On Tang
State Key Laboratory of Chirosciences, Lo Ka Chung Centre for Natural Anti-cancer Drug Development, Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong
6 shared publications
Latest Publications
- 19 April 2017
- Published by Taylor & Francis in Critical Reviews in Microbiology
- Vol. 44 (1) , 40-78
Recent advances on topical antimicrobials for skin and soft tissue infections and their safety concerns
Antimicrobial resistance of disease-related microorganisms is considered a worldwide prevalent and serious issue which increases the failure of treatment outcomes and leads to high mortality. Considering that the increased resistance to systemic antimicrobial therapy often needs of the use of more toxic agents, topical antimicrobial therapy emerges as an attractive route for the treatment of infectious diseases. The topical antimicrobial therapy is based on the absorption of high drug doses in a readily accessible skin surface, resulting in a reduction of microbial proliferation at infected skin sites. Topical antimicrobials retain the following features: (a) they are able to escape the enzymatic degradation and rapid clearance in the gastrointestinal tract or the first-pass metabolism during oral administration; (b) alleviate the physical discomfort related to intravenous injection; (c) reduce possible adverse effects and drug interactions of systemic administrations; (d) increase patient compliance and convenience; and (e) reduce the treatment costs. Novel antimicrobials for topical application have been widely exploited to control the emergence of drug-resistant microorganisms. This review provides a description of antimicrobial resistance, common microorganisms causing skin and soft tissue infections, topical delivery route of antimicrobials, safety concerns of topical antimicrobials, recent advances, challenges and future prospective in topical antimicrobial development.
- 19 April 2017
- Published by Taylor & Francis in Critical Reviews in Microbiology
- Vol. 44 (1) , 40-78
Recent advances on topical antimicrobials for skin and soft tissue infections and their safety concerns
Antimicrobial resistance of disease-related microorganisms is considered a worldwide prevalent and serious issue which increases the failure of treatment outcomes and leads to high mortality. Considering that the increased resistance to systemic antimicrobial therapy often needs of the use of more toxic agents, topical antimicrobial therapy emerges as an attractive route for the treatment of infectious diseases. The topical antimicrobial therapy is based on the absorption of high drug doses in a readily accessible skin surface, resulting in a reduction of microbial proliferation at infected skin sites. Topical antimicrobials retain the following features: (a) they are able to escape the enzymatic degradation and rapid clearance in the gastrointestinal tract or the first-pass metabolism during oral administration; (b) alleviate the physical discomfort related to intravenous injection; (c) reduce possible adverse effects and drug interactions of systemic administrations; (d) increase patient compliance and convenience; and (e) reduce the treatment costs. Novel antimicrobials for topical application have been widely exploited to control the emergence of drug-resistant microorganisms. This review provides a description of antimicrobial resistance, common microorganisms causing skin and soft tissue infections, topical delivery route of antimicrobials, safety concerns of topical antimicrobials, recent advances, challenges and future prospective in topical antimicrobial development.
- 12 January 2017
- Published by Taylor & Francis in Nanomedicine
- Vol. 12 (4) , 357-385
Recent Advances in Green Nanoparticulate Systems for Drug Delivery: Efficient Delivery and Safety Concern
Nanotechnology manipulates therapeutic agents at the nanoscale for the development of nanomedicines. However, there are current concerns over nanomedicines, mainly related to the possible toxicity ...
- 12 January 2017
- Published by Taylor & Francis in Nanomedicine
- Vol. 12 (4) , 357-385
Recent Advances in Green Nanoparticulate Systems for Drug Delivery: Efficient Delivery and Safety Concern
Nanotechnology manipulates therapeutic agents at the nanoscale for the development of nanomedicines. However, there are current concerns over nanomedicines, mainly related to the possible toxicity ...
- 2 November 2016
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 6 (106) , 104575-104581
Antifungal study of substituted 4-pyridylmethylene-4′-aniline Schiff bases
Otomycosis is a superficial infection of the ear caused by fungi. The disease may occur in the pinna, external auditory canal and tympanic membrane of humans and animals. Aspergillus niger and Candida albicans are the most prevalent fungal species responsible for otomycosis. In our study, the potential antifungal properties of a series of Schiff bases was examined. The synthesized compounds (1–14) were investigated for their minimum inhibitory concentration, minimum fungicidal concentration and zone of clearance against Aspergillus niger and Candida albicans. Compounds 5 and 6 with alkyl chain containing 6 or 7 carbon atoms exhibited an obvious fungicidal activity with the MIC/MFC ratio of 2. Zone of clearance study also demonstrated that both compounds 5 and 6 produced noticeable clear zones against the tested fungi as compared to fluconazole. The time-kill kinetic study showed that Candida albicans colonies were reduced by more than 3 logs after 24 h exposure to compound 5 at 4 and 8 × MIC levels. Both compounds 5 and 6 at a concentration of 50 μg mL−1 exhibited satisfactory cell viability towards human skin keratinocytes. Our results suggest that these compounds may be considered as potential drug candidates for the treatment of Aspergillus niger and Candida albicans ear infections.
- 2 November 2016
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 6 (106) , 104575-104581
Antifungal study of substituted 4-pyridylmethylene-4′-aniline Schiff bases
Otomycosis is a superficial infection of the ear caused by fungi. The disease may occur in the pinna, external auditory canal and tympanic membrane of humans and animals. Aspergillus niger and Candida albicans are the most prevalent fungal species responsible for otomycosis. In our study, the potential antifungal properties of a series of Schiff bases was examined. The synthesized compounds (1–14) were investigated for their minimum inhibitory concentration, minimum fungicidal concentration and zone of clearance against Aspergillus niger and Candida albicans. Compounds 5 and 6 with alkyl chain containing 6 or 7 carbon atoms exhibited an obvious fungicidal activity with the MIC/MFC ratio of 2. Zone of clearance study also demonstrated that both compounds 5 and 6 produced noticeable clear zones against the tested fungi as compared to fluconazole. The time-kill kinetic study showed that Candida albicans colonies were reduced by more than 3 logs after 24 h exposure to compound 5 at 4 and 8 × MIC levels. Both compounds 5 and 6 at a concentration of 50 μg mL−1 exhibited satisfactory cell viability towards human skin keratinocytes. Our results suggest that these compounds may be considered as potential drug candidates for the treatment of Aspergillus niger and Candida albicans ear infections.
- 1 May 2016
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 80, 145-150
Antiangiogenic activity of 2-formyl-8-hydroxy-quinolinium chloride
- 1 May 2016
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 80, 145-150
Antiangiogenic activity of 2-formyl-8-hydroxy-quinolinium chloride
- 23 February 2016
- Published by Spandidos Publications in Biomedical Reports
- Vol. 4 (4) , 449-452
Sensitization of Candida albicans to terbinafine by berberine and berberrubine
Candida albicans (C. albicans) is an opportunistic fungal pathogen, particularly observed in immunocompromised patients. C. albicans accounts for 50‑70% of cases of invasive candidiasis in the majority of clinical settings. Terbinafine, an allylamine antifungal drug, has been used to treat fungal infections previously. It has fungistatic activity against C. albicans. Traditional Chinese medicines can be used as complementary medicines to conventional drugs to treat a variety of ailments and diseases. Berberine is a quaternary alkaloid isolated from the traditional Chinese herb, Coptidis Rhizoma, while berberrubine is isolated from the medicinal plant Berberis vulgaris, but is also readily derived from berberine by pyrolysis. The present study demonstrates the possible complementary use of berberine and berberrubine with terbinafine against C. albicans. The experimental findings assume that the potential application of these alkaloids together with reduced dosage of the standard drug would enhance the resulting antifungal potency.
- 23 February 2016
- Published by Spandidos Publications in Biomedical Reports
- Vol. 4 (4) , 449-452
Sensitization of Candida albicans to terbinafine by berberine and berberrubine
Candida albicans (C. albicans) is an opportunistic fungal pathogen, particularly observed in immunocompromised patients. C. albicans accounts for 50‑70% of cases of invasive candidiasis in the majority of clinical settings. Terbinafine, an allylamine antifungal drug, has been used to treat fungal infections previously. It has fungistatic activity against C. albicans. Traditional Chinese medicines can be used as complementary medicines to conventional drugs to treat a variety of ailments and diseases. Berberine is a quaternary alkaloid isolated from the traditional Chinese herb, Coptidis Rhizoma, while berberrubine is isolated from the medicinal plant Berberis vulgaris, but is also readily derived from berberine by pyrolysis. The present study demonstrates the possible complementary use of berberine and berberrubine with terbinafine against C. albicans. The experimental findings assume that the potential application of these alkaloids together with reduced dosage of the standard drug would enhance the resulting antifungal potency.
- 10 February 2016
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 6 (20) , 16736-16744
Antimicrobial and toxicological evaluations of binuclear mercury( ii )bis(alkynyl) complexes containing oligothiophenes and bithiazoles
Metals and metal complexes are promising antimicrobials due to their powerful inhibitory activity against microbes. However, the potential for metal toxicity to life remains unsolved. Mercury is a toxic element with no known positive biological functions, and its toxicity to humans is well known. With the known toxicity of Hg and its complexes, their usefulness for antimicrobial therapy should not be neglected. In this work, we investigated the antimicrobial activity of bis-(alkynyl)mercury(II) complexes with oligothiophene and bithiazole linking units against MRSA and C. albicans (pathogens commonly co-inhabit infected sites), and their cytotoxicity was tested on NIH 3T3 cells. Among the Hg(II) complexes, complex 2 showed potent microcidal activity against MRSA (MIC and MBC values = 0.2 μg mL−1) and C. albicans (MIC and MBC values = 0.4 μg mL−1). Complex 2 displayed a highly distinguished zone of clearance with comparably sharp zone edges on microbial agar plates. Time–kill kinetic studies showed that MRSA colonies were reduced by approximately 5 logs during the initial 3 h exposure to complex 2 at an 8× MIC level. The possible antimicrobial mechanism might be due to the intracellular ROS generation by complex 2 that caused the loss in MRSA viability. Complex 2 exhibited a higher IC50 value (0.8 μg mL−1) towards NIH 3T3 cells that was greater than its corresponding MIC values against tested microbes. Hg(II) complexes would be potent antimicrobials, but a challenge is to fully utilize their potential inhibitory effects on microbes while lowering their toxic levels on human health.
- 10 February 2016
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 6 (20) , 16736-16744
Antimicrobial and toxicological evaluations of binuclear mercury( ii )bis(alkynyl) complexes containing oligothiophenes and bithiazoles
Metals and metal complexes are promising antimicrobials due to their powerful inhibitory activity against microbes. However, the potential for metal toxicity to life remains unsolved. Mercury is a toxic element with no known positive biological functions, and its toxicity to humans is well known. With the known toxicity of Hg and its complexes, their usefulness for antimicrobial therapy should not be neglected. In this work, we investigated the antimicrobial activity of bis-(alkynyl)mercury(II) complexes with oligothiophene and bithiazole linking units against MRSA and C. albicans (pathogens commonly co-inhabit infected sites), and their cytotoxicity was tested on NIH 3T3 cells. Among the Hg(II) complexes, complex 2 showed potent microcidal activity against MRSA (MIC and MBC values = 0.2 μg mL−1) and C. albicans (MIC and MBC values = 0.4 μg mL−1). Complex 2 displayed a highly distinguished zone of clearance with comparably sharp zone edges on microbial agar plates. Time–kill kinetic studies showed that MRSA colonies were reduced by approximately 5 logs during the initial 3 h exposure to complex 2 at an 8× MIC level. The possible antimicrobial mechanism might be due to the intracellular ROS generation by complex 2 that caused the loss in MRSA viability. Complex 2 exhibited a higher IC50 value (0.8 μg mL−1) towards NIH 3T3 cells that was greater than its corresponding MIC values against tested microbes. Hg(II) complexes would be potent antimicrobials, but a challenge is to fully utilize their potential inhibitory effects on microbes while lowering their toxic levels on human health.
- 10 December 2014
- Published by Royal Society of Chemistry (RSC) in Green Chemistry
- Vol. 17 (3) , 1640-1646
Evaluation of berberine/bovine serum albumin nanoparticles for liver fibrosis therapy
Excretion of hazardous pharmaceutical residues causes the emergence of toxic potential to the environment. Nanomedicine is commonly associated with nanoparticulate drug delivery to offer the improved therapeutic effects at a lower dose for disease treatments. Green chemistry aims to reduce or exclude the utilisation or generation of toxic substances in the design, manufacture and application of chemical products. The use of non-toxic and biodegradable materials in pharmaceutical formulations could minimize the adverse effects of pharmaceutical residues entering the environment in the first place. In our study, bovine serum albumin, a non-toxic, biodegradable and biocompatible protein, was used in the formation of nanoparticulate drug delivery systems. Glucose was used instead of glutaraldehyde to modify albumin nanoparticles for berberine delivery in order to prevent the potential toxicity to humans and the environment. These nanoparticles highly inhibited LX-2 cell growth and exhibited stronger caspase 3 activation at a lower dose when compared with free drug in vitro. Nanoparticles with berberine at doses of 1 and 2 μg g−1 could rescue mice from CCl4-induced hepatotoxicity in vivo. Green glucose-bovine serum albumin nanoparticles could be safe and effective to deliver berberine at low doses in liver fibrosis treatment.
- 10 December 2014
- Published by Royal Society of Chemistry (RSC) in Green Chemistry
- Vol. 17 (3) , 1640-1646
Evaluation of berberine/bovine serum albumin nanoparticles for liver fibrosis therapy
Excretion of hazardous pharmaceutical residues causes the emergence of toxic potential to the environment. Nanomedicine is commonly associated with nanoparticulate drug delivery to offer the improved therapeutic effects at a lower dose for disease treatments. Green chemistry aims to reduce or exclude the utilisation or generation of toxic substances in the design, manufacture and application of chemical products. The use of non-toxic and biodegradable materials in pharmaceutical formulations could minimize the adverse effects of pharmaceutical residues entering the environment in the first place. In our study, bovine serum albumin, a non-toxic, biodegradable and biocompatible protein, was used in the formation of nanoparticulate drug delivery systems. Glucose was used instead of glutaraldehyde to modify albumin nanoparticles for berberine delivery in order to prevent the potential toxicity to humans and the environment. These nanoparticles highly inhibited LX-2 cell growth and exhibited stronger caspase 3 activation at a lower dose when compared with free drug in vitro. Nanoparticles with berberine at doses of 1 and 2 μg g−1 could rescue mice from CCl4-induced hepatotoxicity in vivo. Green glucose-bovine serum albumin nanoparticles could be safe and effective to deliver berberine at low doses in liver fibrosis treatment.
- 2 September 2014
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 24 (4) , 1568-1577
Development of 8-benzyloxy-substituted quinoline ethers and evaluation of their antimicrobial activities
- 2 September 2014
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 24 (4) , 1568-1577
Development of 8-benzyloxy-substituted quinoline ethers and evaluation of their antimicrobial activities
- 15 August 2014
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 4 (73) , 38839-38847
Preparation and characterization of bio-safe activated charcoal derived from coffee waste residue and its application for removal of lead and copper ions
Activated charcoal was prepared by the pyrolysis of coffee ground waste residues impregnated by phosphoric acid and potassium hydroxide at 600 °C. In our study, spent coffee was collected from the university canteen and the prepared activated charcoal impregnated with potassium hydroxide gave the highest surface area of 708.1 ± 0.1 m2 g−1, which was determined by using the methylene blue adsorption method. The activated charcoal was characterized by using scanning electron microscopy and Fourier transform infrared spectroscopy. In order to ensure that the activated charcoal produced is bio-safe, all samples were tested for possible toxic substances, including toxic heavy metals by using ICP-OES, and toxic organics such as acrylamide by using chromatography methods. In addition, all samples showed no ecotoxicity towards Escherichia coli and no cytotoxicity toward human HaCaT skin cells. The phosphoric acid activated charcoal demonstrated a high Qmax of 95.2 and 38.2 mg g−1, respectively for lead and copper adsorption. For potassium hydroxide activated charcoal, the values of Qmax were found to be 45.4 and 21.2 mg g−1, respectively for lead and copper adsorption.
- 15 August 2014
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 4 (73) , 38839-38847
Preparation and characterization of bio-safe activated charcoal derived from coffee waste residue and its application for removal of lead and copper ions
Activated charcoal was prepared by the pyrolysis of coffee ground waste residues impregnated by phosphoric acid and potassium hydroxide at 600 °C. In our study, spent coffee was collected from the university canteen and the prepared activated charcoal impregnated with potassium hydroxide gave the highest surface area of 708.1 ± 0.1 m2 g−1, which was determined by using the methylene blue adsorption method. The activated charcoal was characterized by using scanning electron microscopy and Fourier transform infrared spectroscopy. In order to ensure that the activated charcoal produced is bio-safe, all samples were tested for possible toxic substances, including toxic heavy metals by using ICP-OES, and toxic organics such as acrylamide by using chromatography methods. In addition, all samples showed no ecotoxicity towards Escherichia coli and no cytotoxicity toward human HaCaT skin cells. The phosphoric acid activated charcoal demonstrated a high Qmax of 95.2 and 38.2 mg g−1, respectively for lead and copper adsorption. For potassium hydroxide activated charcoal, the values of Qmax were found to be 45.4 and 21.2 mg g−1, respectively for lead and copper adsorption.